Image pharmaphorum Editor News Hepatitis drug wins award for cure rate and efficacy Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial. News Sanofi stockpiles drugs in case of no-deal Brexit Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of News Roche’s MS drug Ocrevus earns blockbuster status a year afte... Roche’s multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has claimed blockbuster status just one year after it was launched. News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety. Load more results
News Hepatitis drug wins award for cure rate and efficacy Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial.
News Sanofi stockpiles drugs in case of no-deal Brexit Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of
News Roche’s MS drug Ocrevus earns blockbuster status a year afte... Roche’s multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has claimed blockbuster status just one year after it was launched.
News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
